Scientists have designed a novel wireless device which may accurately detect heart dysfunction in children who survived cancer.
Childhood cancer survivors are advised to undergo screening for the detection of heart dysfunction because of known anthracycline-induced cardiotoxicity. However, screening with echocardiography-the standard of care -for monitoring heart function- can be highly variable and limited.
Another alternative is cardiac-magnetic resonance (CMR) imaging which is expensive and not widely accessible. Now, a prototype hand held instrument which collects pulse waves and phonocardiogram data from the carotid artery which revealed the device to be accurate and it also displayed a low false negative rate as compared to CMR imaging.

_Health_